Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/15/2013

Company Name Symbol %Change
A M R CP AAMRQ
9.67%
KRATOS DEFEN KTOS
6.22%
NOAH HOLDING NOAH
5.15%
AETERNA ZENT AEZS
3.67%
QIHOO 360 TE QIHU
3.02%
Priceline.com (PCLN) Could Fall Through $750.81 Support Level

Print Share

May 14, 2013 (Marketintelligencecenter.com via COMTEX) -- priceline.com Inc (NASDAQ:PCLN) closed Monday's trading session at $777.44. In the past year, the stock has hit a 52-week low of $553.42 and 52-week high of $779.25. Priceline.com (PCLN) stock has been showing support around $750.81 and resistance in the $792.57 range. Technical indicators for the stock are Bullish and S&P gives Priceline.com (PCLN) a neutral 3 STARS (out of 5) hold rating. For a hedged play on Priceline.com (PCLN), look at the Jul '13 $820.00 covered call for a net debit in the $762.94 area. That is also the break-even stock price for this trade. This covered call has a duration of 67 days, provides 1.87% downside protection and an assigned return rate of 7.48% for an annualized return rate of 40.74% (for comparison purposes only). A lower-cost hedged play for Priceline.com (PCLN) would use a longer term call option in place of the covered call stock purchase. To use this strategy look at going long the Priceline.com (PCLN) Jan '14 $605.00 call and selling the Jul '13 $820.00 call for a total debit of $176.40. The trade has a lifespan of 67 days and would provide -0.51% downside protection and an assigned return rate of 21.88% for an annualized return rate of 119% (for comparison purposes only). Priceline.com (PCLN) has a current trailing average dividend yield of 0%.

MarketIntelligenceCenter.com

(C) Copyright 2013, Marketintelligencecenter.com. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.